Morgan Stanley analyst Patrick Wood maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight and maintains $45 price target.
Morgan Stanley Maintains Equal-Weight on Tandem Diabetes Care, Maintains $45 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.